A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy of Omalizumab in Prevention of Bronchoconstriction Following Environmental Aeroallergen Exposure

被引：1
|
作者：
Corren, J. [1 ]
Wood, R. A. [2 ]
Patel, D. [3 ]
Zhu, J. [4 ]
Fish, J. E. [5 ]
机构：
[1] Allergy Res Fdn, Allergy Med Clin, Los Angeles, CA USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Cetero Res, Mississauga, ON, Canada
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Thomas Jefferson Univ, Gladwyne, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 125卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2009.12.282
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB72 / AB72
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [22] Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study
    Hui Zhang
    Chuan-Ling Li
    Feng Wan
    Su-Juan Wang
    Xiu-E Wei
    Yan-Lei Hao
    Hui-Lin Leng
    Jia-Min Li
    Zhong-Rui Yan
    Bao-Jun Wang
    Ren-Shi Xu
    Ting-Min Yu
    Li-Chun Zhou
    Dong-Sheng Fan
    NeuralRegenerationResearch, 2020, 15 (07) : 1266 - 1273
  • [23] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
    Reetz, Kathrin
    Hilgers, Ralf-Dieter
    Isfort, Susanne
    Dohmen, Marc
    Didszun, Claire
    Fedosov, Kathrin
    Kistermann, Jennifer
    Mariotti, Caterina
    Durr, Alexandra
    Boesch, Sylvia A.
    Klopstock, Thomas
    Garrido, Francisco Javier Rodriguez de Rivera
    Schoels, Ludger
    Klockgether, Thomas
    Pandolfo, Massimo
    Korinthenberg, Rudolf
    Lavin, Philip
    Molenberghs, Geert
    Libri, Vincenzo
    Giunti, Paola
    Festenstein, Richard
    Schulz, Joerg B.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
  • [24] Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study
    Chang, Young Hoon
    Choi, Yoon Jin
    Shin, Cheol Min
    Moon, Jin Seok
    Kim, Tae-Yoon
    Yoon, Hyuk
    Park, Young Soo
    Kim, Nayoung
    Lee, Dong Ho
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 30 (01) : 73 - 86
  • [25] Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction: a randomized, double-blind, parallel-group, placebo-controlled study
    Zhang, Hui
    Li, Chuan-Ling
    Wan, Feng
    Wang, Su-Juan
    Wei, Xiu-E
    Hao, Yan-Lei
    Leng, Hui-Lin
    Li, Jia-Min
    Yan, Zhong-Rui
    Wang, Bao-Jun
    Xu, Ren-Shi
    Yu, Ting-Min
    Zhou, Li-Chun
    Fan, Dong-Sheng
    NEURAL REGENERATION RESEARCH, 2020, 15 (07) : 1266 - 1273
  • [26] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
    Kathrin Reetz
    Ralf-Dieter Hilgers
    Susanne Isfort
    Marc Dohmen
    Claire Didszun
    Kathrin Fedosov
    Jennifer Kistermann
    Caterina Mariotti
    Alexandra Durr
    Sylvia Boesch
    Thomas Klopstock
    Francisco Javier Rodríguez de Rivera Garrido
    Ludger Schöls
    Thomas Klockgether
    Massimo Pandolfo
    Rudolf Korinthenberg
    Philip Lavin
    Geert Molenberghs
    Vincenzo Libri
    Paola Giunti
    Richard Festenstein
    Jörg B. Schulz
    Neurological Research and Practice, 1
  • [27] Transdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatients
    Bodkin, JA
    Amsterdam, JD
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (11): : 1869 - 1875
  • [28] CETACAINE EFFICACY - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    LACHTER, J
    JACOBS, R
    LAVY, A
    SUISSA, A
    WEISLER, A
    EIDELMAN, S
    GASTROENTEROLOGY, 1988, 94 (05) : A245 - A245
  • [29] A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of XOLAIR® (omalizumab) in peanut allergy (TOPS)
    Sampson, H. A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S117 - S117
  • [30] Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial
    Ethel Ciampi
    Reinaldo Uribe-San-Martin
    Claudia Cárcamo
    Juan Pablo Cruz
    Ana Reyes
    Diego Reyes
    Carmen Pinto
    Macarena Vásquez
    Rafael A. Burgos
    Juan Hancke
    BMC Neurology, 20
12345